- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04:59 | Histogen Files For Voluntary Chapter 11 Bankruptcy Protection | - | RTTNews | ||
| 04:58 | Celltrion releases Remsima SC in Denmark | - | Korea Economic Daily | ||
| 03:10 | Inoviq closes the gap on blood test results for ovarian cancer | 1 | The Market Herald Australia | ||
| 02:42 | Glow Lifetech Corp: Glow Lifetech to be late to file 2023 results | 1 | Stockwatch | ||
| 02:26 | Glow LifeTech Corp.: Glow Announces Late Filing of Financial Statements | 209 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 18, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) ("Glow" or the "Company") announces that the Company is currently seeking a new auditor to perform... ► Artikel lesen | |
| 02:06 | Earnings call: Hansa Biopharma reports strong Q1 and optimistic outlook | 1 | Investing.com | ||
| 00:58 | Column: Law firm Edelson pitches radical idea for picking lead in 23andMe case. Ask class members. | 1 | Reuters | ||
| 00:47 | GENETIC TECHNOLOGIES LIMITED: Proposed issue of securities - GTG | - | ASX | ||
| 00:47 | GENETIC TECHNOLOGIES LIMITED: GTG announces US$2 Million Registered Direct Offering | - | ASX | ||
| 00:46 | 23andMe: What If … | 1 | MedCity News | ||
| 00:45 | Amgen Aktie: Tezspire als COPD-Potenzial | 455 | Börse Global | Amgen, der weltweit größte Biotech-Arzneimittelhersteller, hat in der jüngsten Marktschließung einen leichten Rückgang auf $264.07 verzeichnet, obwohl dies hinter dem allgemeinen Verlust des S&P 500... ► Artikel lesen | |
| 00:00 | Histogen files for Chapter 11, seeks liquidation | 1 | Seeking Alpha | ||
| Do | INOVIQ LTD: Ovarian Cancer Test Validation | - | ASX | ||
| Do | Histogen Inc: Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering | 1 | GlobeNewswire (USA) | ||
| Do | Integra LifeSciences Holdings Corporation: Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 | 1 | GlobeNewswire (USA) | ||
| Do | Entheon Biomedical Corp (2): Entheon Biomedical closes $147,500 private placement | 1 | Stockwatch | ||
| Do | Enliven Therapeutics files to sell 6.43M shares for holders | 1 | Seeking Alpha | ||
| Do | Sana Biotechnology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Do | FYBR, BCRX and SABR are among after hour movers | 4 | Seeking Alpha | ||
| Do | Surrozen files to sell 1.09M shares of common stock for holders | 1 | Seeking Alpha |
Seite:
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| 23ANDME | 15 | 16 | 0,00 % | Column: Law firm Edelson pitches radical idea for picking lead in 23andMe case. Ask class members. | |||
| EVOTEC | 11 | 40 | +1,82 % | Deutsche Telekom, Evotec, Morphosys, Mutares, Nel ASA - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | ||
| BENITEC BIOPHARMA | 7 | 7 | 0,00 % | Benitec Biopharma Inc.: Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study | -First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements... ► Artikel lesen | ||
| CK LIFE SCIENCES INTERNATIONAL HOLDINGS | 6 | 6 | +1,43 % | CKLIFE SCIENCES (00775): SUSTAINABILITY REPORT 2023 | |||
| CARSGEN THERAPEUTICS | 6 | 6 | - | CARSGEN-B (02171): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | |||
| BIO-PATH | 5 | 8 | 0,00 % | Bio-Path Holdings, Inc.: Bio-Path Holdings Expands Global Patent Portfolio | HOUSTON, April 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop... ► Artikel lesen | ||
| MORPHOSYS | 4 | 27 | 0,00 % | EQS-PVR: MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: MorphoSys AG
MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
18.04.2024 / 16:01 CET/CEST
Veröffentlichung... ► Artikel lesen | ||
| OCULAR THERAPEUTIX | 4 | 8 | +0,36 % | Ocular Therapeutix, Inc.: Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathy | 46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0% in the control arm No patients in the AXPAXLI... ► Artikel lesen | ||
| GENETIC TECHNOLOGIES | 4 | 7 | +6,11 % | Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESSWIRE / April 12, 2024 / RedChip Companies will air interviews with Genetic Technologies Limited (NASDAQ:GENE) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks, Big Money... ► Artikel lesen | ||
| KORRO BIO | 4 | 4 | 0,00 % | Korro secures $70M financing via private placement |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| BIO-GATE AG | 1,030 | 4,20 | +308 % | 1 | - | - | |||
| EVOTEC SE | 13,450 | 22,65 | +68 % | 6 | - | - | |||
| SARTORIUS STEDIM BIOTECH SA | 208,10 | 330 | +59 % | 1 | - | - | |||
| QIAGEN NV | 37,030 | 54,20 | +46 % | 8 | 3 | - | |||
| BIONTECH SE ADR | 80,60 | 91,02 | +13 % | - | 5 | - | |||
| MORPHOSYS AG | 67,70 | 41,33 | -39 % | 7 | 3 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
